353 related articles for article (PubMed ID: 26967051)
1. Lipidome in colorectal cancer.
Yan G; Li L; Zhu B; Li Y
Oncotarget; 2016 May; 7(22):33429-39. PubMed ID: 26967051
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and colorectal cancer: implications for therapy.
Yang SY; Sales KM; Fuller B; Seifalian AM; Winslet MC
Trends Mol Med; 2009 May; 15(5):225-33. PubMed ID: 19362056
[TBL] [Abstract][Full Text] [Related]
3. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
[TBL] [Abstract][Full Text] [Related]
4. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
Liu L; Wong CC; Gong B; Yu J
Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of Fatty Acid Synthesis and Oxidation as Potential Anticancer Agents in Colorectal Cancer Treatment.
Mozolewska P; Duzowska K; Pakiet A; Mika A; ŚledziŃski T
Anticancer Res; 2020 Sep; 40(9):4843-4856. PubMed ID: 32878772
[TBL] [Abstract][Full Text] [Related]
6. NF-κB pathways in the development and progression of colorectal cancer.
Patel M; Horgan PG; McMillan DC; Edwards J
Transl Res; 2018 Jul; 197():43-56. PubMed ID: 29550444
[TBL] [Abstract][Full Text] [Related]
7. Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer.
Akil H; Perraud A; Jauberteau MO; Mathonnet M
World J Gastroenterol; 2016 Jan; 22(2):490-500. PubMed ID: 26811602
[TBL] [Abstract][Full Text] [Related]
8. The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications.
de Freitas Junior JC; Morgado-Díaz JA
Oncotarget; 2016 Apr; 7(15):19395-413. PubMed ID: 26539643
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer.
Camp ER; Patterson LD; Kester M; Voelkel-Johnson C
Cancer Biol Ther; 2017 Sep; 18(9):640-650. PubMed ID: 28686076
[TBL] [Abstract][Full Text] [Related]
10. Anti-metastatic treatment in colorectal cancer: targeting signaling pathways.
Lemos C; Sack U; Schmid F; Juneja M; Stein U
Curr Pharm Des; 2013; 19(5):841-63. PubMed ID: 22973955
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
12. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
Cabrero-de Las Heras S; Martínez-Balibrea E
World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
[TBL] [Abstract][Full Text] [Related]
13. Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer.
Moradi-Marjaneh R; Hassanian SM; Fiuji H; Soleimanpour S; Ferns GA; Avan A; Khazaei M
J Cell Physiol; 2018 Aug; 233(8):5613-5622. PubMed ID: 29150944
[TBL] [Abstract][Full Text] [Related]
14. Input of microenvironmental regulation on colorectal cancer: role of the CCN family.
Chang CC; Lin BR; Wu TS; Jeng YM; Kuo ML
World J Gastroenterol; 2014 Jun; 20(22):6826-31. PubMed ID: 24944473
[TBL] [Abstract][Full Text] [Related]
15. Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents.
Liu X; Ji Q; Fan Z; Li Q
Future Oncol; 2015; 11(21):2911-22. PubMed ID: 26414153
[TBL] [Abstract][Full Text] [Related]
16. Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression.
Lu W; Wang J; Yang G; Yu N; Huang Z; Xu H; Li J; Qiu J; Zeng X; Chen S; Li N; Liu H
Oncotarget; 2017 Feb; 8(9):15242-15251. PubMed ID: 28146425
[TBL] [Abstract][Full Text] [Related]
17. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
[TBL] [Abstract][Full Text] [Related]
18. The role of microRNAs in colorectal cancer.
Mohammadi A; Mansoori B; Baradaran B
Biomed Pharmacother; 2016 Dec; 84():705-713. PubMed ID: 27701052
[TBL] [Abstract][Full Text] [Related]
19. Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.
Cathcart MC; Lysaght J; Pidgeon GP
Cancer Metastasis Rev; 2011 Dec; 30(3-4):363-85. PubMed ID: 22134655
[TBL] [Abstract][Full Text] [Related]
20. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
